From the Chairmans address at AGM 4th May:
'The USFDA has advised of its goal date to complete its full review of the NDA late next month, after which time, we expect to secure approval and begin US sales as soon as is practicable.'
So end June early July for approval
- Forums
- ASX - By Stock
- Ann: Confirmation of Technegas USFDA Timetable
CYC
cyclopharm limited
Add to My Watchlist
1.10%
!
92.0¢

From the Chairmans address at AGM 4th May:'The USFDA has advised...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
92.0¢ |
Change
0.010(1.10%) |
Mkt cap ! $102.2M |
Open | High | Low | Value | Volume |
91.5¢ | 92.0¢ | 90.0¢ | $37.47K | 41.04K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 8100 | 91.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
92.0¢ | 56000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 8100 | 0.910 |
1 | 1000 | 0.905 |
2 | 2279 | 0.900 |
2 | 1830 | 0.890 |
1 | 2000 | 0.885 |
Price($) | Vol. | No. |
---|---|---|
0.920 | 56000 | 1 |
0.950 | 14000 | 1 |
1.000 | 1252 | 2 |
1.015 | 15490 | 1 |
1.025 | 11341 | 1 |
Last trade - 15.57pm 01/07/2025 (20 minute delay) ? |
Featured News
CYC (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Dr. Steven Gourlay, CEO
Dr. Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online